Emerging therapeutics targeting the PI3K/Akt/GSK-3β in calcium dysregulation in Alzheimer’s disease
Cell Calcium · 2026-01 · 133 · 103107
DOI: 10.1016/j.ceca.2025.103107 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Calcium, 2026-01. Verfasst von Simran Soni und 1 weiteren Autor:innen. Beteiligte Einrichtung: Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed-to-be Un…. Hauptthemen laut MEDLINE: Alzheimer Disease, Glycogen Synthase Kinase 3 beta, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 83 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed-to-be University, Vile Parle (West), Mumbai, Maharashtra, 400056, India.
- Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed-to-be University, Vile Parle (West), Mumbai, Maharashtra, 400056, India. Elect…
Zitieren
APA
Soni, S., & Kaur, G. (2026). Emerging therapeutics targeting the PI3K/Akt/GSK-3β in calcium dysregulation in Alzheimer’s disease. Cell Calcium, 133, 103107. https://doi.org/10.1016/j.ceca.2025.103107
Vancouver
Soni S, Kaur G. Emerging therapeutics targeting the PI3K/Akt/GSK-3β in calcium dysregulation in Alzheimer’s disease. Cell Calcium. 2026;133:103107. doi:10.1016/j.ceca.2025.103107
BibTeX
@article{Soni2026,
author = {Soni, Simran and Kaur, Ginpreet},
title = {Emerging therapeutics targeting the PI3K/Akt/GSK-3β in calcium dysregulation in Alzheimer’s disease},
journal = {Cell Calcium},
year = {2026},
volume = {133},
pages = {103107},
doi = {10.1016/j.ceca.2025.103107}
}
EUVIMED